Tuesday, August 22, 2017
Company News: Page (1) of 1 - 08/11/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Flo Reaches 10M MAU and Raises $5M in Series A to Advance Women's Health
(August 11, 2017)

SAN FRANCISCO, Aug. 11, 2017 /PRNewswire/ -- Flo, the fastest growing AI-driven women's health platform, today announced it has raised $5M in a Series A round. The round was led by Flint Capital, along with Natalia Vodianova, a supermodel, social activist and a mother of 5, who also joined Board of Directors, and a few angel investors.

"We are thrilled to support Flo, and to lead this investment in the company. Flo has a strong team with great experience, a clear vision and deep market understanding," said Andrew Gershfeld, Partner at Flint Capital.

Since its launch as a period tracker in October 2015, Flo has attracted over 10 million monthly active users and is currently growing by 1 million MAU each month. New features, including personalized health insights and a closed anonymous community of experts and peers, have helped the product to evolve into a full-fledged women's health platform. With a pregnancy mode added, the Flo app can now offer a tailored health solution for women at any stage of the reproductive cycle. Currently, 100,000 women get pregnant each month with help from Flo.

"Flo is a strong tool for preventive medicine," said Yuri Gurski, Flo Founder and President. "Users can simply download Flo to track periods, but then continue to use it to better understand their body, feel calm and confident about their health. Most importantly, users' data is a 100% secure and confidential."

Joining forces with Natalia Vodianova, a supermodel and a social activist, Flo will embark on a mission to empower women by encouraging them to speak freely about their physical and mental wellbeing. A new campaign "Let's Talk about it. Period." is about to launch this September worldwide.

"When I started using Flo, I became very impressed with its accuracy, amazing insights, and most importantly, the community of women freely and supportively talking with each other on the most important and often silenced subjects - menstruation, women's health and motherhood," added Natalia Vodianova.

The company's rapid progress is attributed to the team's vast experience. Among its co-founders are Yuri Gurski, advisor and investor to MSQRD (acquired by Facebook), Prisma and MAPS.ME; former Vice President at Mail.ru, Eastern European internet giant. Advisors and early stage investors include Matvey Timoshenko and Peter Skoromnyi, co-founders of Apalon, mobile app developer acquired by IAC in 2014.

The Series A investment will help accelerate the company's growth, and to expand its presence into the US market. The company also plans to partner with top medical research centers and universities to advance female health science. The company's ultimate ambition is to become the number 1 female health platform in the world, with at least 100 million users.

Flo is available in 20 languages on iOS and Android. Flo holds the #1 position among competitors in the App Store in 50+ countries, including USA. 


Anastasiya Bardunova

[email protected]



View original content:http://www.prnewswire.com/news-releases/flo-reaches-10m-mau-and-raises-5m-in-series-a-to-advance-womens-health-300503363.html

SOURCE OWHealth Inc.

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Internet, Female, Web, Research, USA, Science, Internet Technology, Medical, Internet, Science, Other, Women,
Related Sites: DMN Newswire ,   CEN - Consumer Electronics Net ,   CEN - Web ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: CEN - Gadgets Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • Informa Names Sixth Annual SupplySide CPG Editors Choice Award Finalists
  • Growth Opportunities in the Global Sleep Apnea Devices Market 2017: Segmented by Product type, Treatment Devices, End-User and Geography - Growth, Trends, and Forecasts (2017 - 2024)
  • BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
  • Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research

  • Gaucher Disease Market Is Anticipated To Witness Growth Owing To Increasing R&D Activities And Special Facility For Orphan Drugs Till 2021 | Million Insights
  • CytRx Corporation Files Preliminary Proxy Statement for Upcoming Special Meeting
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines